XML 61 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Dec. 30, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]        
Financing Receivable, Sale $ 137,400 $ 161,400    
Financing Receivable, Significant Sales, Transaction Fees 2,200 2,000    
Basic:        
Net income $ 81,157 $ 185,801    
Shares (in shares) 159,812,000 160,145,000    
Per Share (in usd per share) $ 0.51 $ 1.16    
Effect of dilutive securities: [Abstract]        
Add: Option shares in the money and dilutive effect of non-vested stock (in shares) 3,053,000 3,419,000    
Less: Pro forma treasury shares (in shares) (960,000) (747,000)    
Diluted:        
Net Income $ 81,157 $ 185,801    
Shares (in shares) 161,905,000 162,817,000    
Per Share (in usd per share) $ 0.50 $ 1.14    
Antidilutive Securities [Abstract]        
Cash and cash equivalents $ 145,473   $ 126,502  
Restricted cash 4,086   292  
Restricted cash included in other long-term assets 143,076   137,656  
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 292,635 $ 261,839 264,450 $ 150,168
Revision of Prior Period, Error Correction, Adjustment        
Antidilutive Securities [Abstract]        
Net Income (Loss), Period Adjustments $ 17,900      
Revision of Prior Period, Error Correction, Adjustment | Overstatement        
Antidilutive Securities [Abstract]        
Inventory, Adjustments     $ 25,100  
Stock Options [Member]        
Antidilutive Securities [Abstract]        
Antidilutive securities excluded from computation of earnings per share (in shares) 0 0    
Non Vested Stock [Member]        
Antidilutive Securities [Abstract]        
Antidilutive securities excluded from computation of earnings per share (in shares) 576,692 333,085